Similar phenomenon was also observed in selected cancers, albeit not common in all cancers, thus suggesting cancer-type difference.36–39 Thus, we believe that therapeutic effects exerted by TCP and GSK-J1 probably result from LSD1 and JMJD3 inhibition, not only their activities but also their expression in HNSCC. This evidence concerns the gene KDM6B and cancer.